Onglyza and Kombiglyze XR are type 2 diabetes drugs manufactured and sold by Bristol-Meyers Squibb Company and AstraZeneca Pharmaceuticals LP. A 2014 FDA study showed that patients taking Onglyza had a higher risk of potentially fatal heart failure. In 2016, the FDA added a stronger warning on Onglyza's label.
The Onglyza Litigation Group provides a forum for sharing information, ideas, and materials, while educating members. Members will receive the most up to date information about the litigation, science, and injuries.
This Litigation Group was formed in February 2018.
The Onglyza Heart Failure Litigation Group provides a forum for lawyers litigating cases to share knowledge, strategies, and educational resources. The Litigation Group has a secure, members-only list server and document library where members can share pertinent information and documents regarding the litigation. This Litigation Group holds regular meetings that are closed to members only to discuss current cases and important updates.
AAJ Annual and Winter Conventions, or as need by group members.